Tinnitus and Hyperacusis (TH)

RP305 - Bimodal Neuromodulation with Sound and Tongue Stimulation Reduces Tinnitus Symptoms

Friday, April 1, 2022

10:45 AM – 11:15 AM CT

Location: 225

Earn 0.05 CEUs

Lead Presenter(s)

Tish Ramirez, AuD

Neuromod Devices

Disclosure: Financial Disclosures: Neuromod USA, Incorporated- Employment
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.

PDF Slides

Abstract: Tinnitus affects 10-15% of the population. A non-invasive device (Lenire) using auditory and tongue stimulation was developed and evaluated in two large randomized and blinded clinical trials (517 tinnitus participants). The talk will present the stimuli used in each study and the treatment outcomes on tinnitus symptom severity. Overall, Lenire provides safe, fast-acting (within 6 weeks) and reproducible therapeutic effects that can last at least 12 months. Furthermore, adjusting the stimulation settings over time can drive greater therapeutic effects.

Learning Objectives:

Describe the treatment benefits possible with bimodal neuromodulation for tinnitus, assess which stimulation parameters are effective, and identify how audiologists and hearing specialists can implement this treatment to their patients.